CIK 0001157601
- Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Open-market buy Director bought 20,000 shares at $2.88 ($57,600)
- 4 Open-market buy President and CEO bought 20,000 shares at an average $2.85 ($57,009)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 16,806 shares (grant or award)
- 4 Grant or award Director acquired 16,806 shares (grant or award)
- 4 Grant or award Director acquired 4,201 shares (grant or award)
- 4 Grant or award Director acquired 8,403 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale Sr. VP, Pgm Mgmt and Clin Ops sold 4,573 shares at $6.20 ($28,375)
- 4 Open-market sale VP, Fin. and Admin., CFO sold 5,600 shares at $6.18 ($34,619)
- 4 Open-market sale VP, IP and Legal, Gen. Counsel sold 5,000 shares at $6.18 ($30,888)
Page 25 of 29 · 564 filings